Cargando...

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation

Currently, several α-synuclein immunotherapies are being tested in experimental Parkinson’s disease models and in clinical trials. Recent research has revealed that α-synuclein is not just an intracellular synaptic protein but also exists extracellularly. Moreover, the transfer of misfolded α-synucl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Parkinsons Dis
Main Authors: George, Sonia, Brundin, Patrik
Formato: Artigo
Idioma:Inglês
Publicado: IOS Press 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4923719/
https://ncbi.nlm.nih.gov/pubmed/26406122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-150630
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!